Progyny (NASDAQ:PGNY) and BrightSpring Health Services (NASDAQ:BTSG) Critical Analysis

Progyny (NASDAQ:PGNY) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership.

Volatility and Risk

Progyny has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its stock price is 87% more volatile than the S&P 500.

Insider and Institutional Ownership

94.9% of Progyny shares are held by institutional investors. 9.9% of Progyny shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Progyny and BrightSpring Health Services”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.29 billion	1.62	$58.52 million	$0.77	34.58
BrightSpring Health Services	$12.91 billion	1.02	$190.67 million	$1.41	47.40

BrightSpring Health Services has higher revenue and earnings than Progyny. Progyny is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Progyny and BrightSpring Health Services, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0	3	11	0	2.79
BrightSpring Health Services	0	0	16	2	3.11

Progyny currently has a consensus target price of $29.92, indicating a potential upside of 12.34%. BrightSpring Health Services has a consensus target price of $61.27, indicating a potential downside of 8.34%. Given Progyny’s higher possible upside, research analysts clearly believe Progyny is more favorable than BrightSpring Health Services.

Profitability

This table compares Progyny and BrightSpring Health Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Progyny	5.23%	13.34%	9.03%
BrightSpring Health Services	2.27%	14.63%	4.41%

Summary

BrightSpring Health Services beats Progyny on 9 of the 15 factors compared between the two stocks.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

About BrightSpring Health Services

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.